JPWO2023190826A5 - - Google Patents
Info
- Publication number
- JPWO2023190826A5 JPWO2023190826A5 JP2024512770A JP2024512770A JPWO2023190826A5 JP WO2023190826 A5 JPWO2023190826 A5 JP WO2023190826A5 JP 2024512770 A JP2024512770 A JP 2024512770A JP 2024512770 A JP2024512770 A JP 2024512770A JP WO2023190826 A5 JPWO2023190826 A5 JP WO2023190826A5
- Authority
- JP
- Japan
- Prior art keywords
- acetamide
- sulfamoylphenyl
- phenyl
- chlorophenyl
- pyrazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022060261 | 2022-03-31 | ||
| PCT/JP2023/013084 WO2023190826A1 (ja) | 2022-03-31 | 2023-03-30 | 偽アレルギー反応に伴う症状の予防若しくは抑制又は治療用の医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023190826A1 JPWO2023190826A1 (https=) | 2023-10-05 |
| JPWO2023190826A5 true JPWO2023190826A5 (https=) | 2026-03-09 |
Family
ID=88202752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512770A Pending JPWO2023190826A1 (https=) | 2022-03-31 | 2023-03-30 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20260000678A1 (https=) |
| EP (1) | EP4501357A1 (https=) |
| JP (1) | JPWO2023190826A1 (https=) |
| CN (1) | CN119233829A (https=) |
| AU (1) | AU2023244778A1 (https=) |
| CA (1) | CA3246964A1 (https=) |
| WO (1) | WO2023190826A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025205829A1 (ja) * | 2024-03-26 | 2025-10-02 | 国立研究開発法人国立循環器病研究センター | 脳動脈瘤の予防又は治療用の医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2397480T3 (da) | 2009-02-16 | 2013-09-02 | Nippon Chemiphar Co | Diazepindionderivat |
| JP6207399B2 (ja) | 2012-01-13 | 2017-10-04 | 日本ケミファ株式会社 | Ｐ２ｘ４受容体拮抗剤 |
| EP3020707B1 (en) | 2013-07-12 | 2019-08-21 | Nippon Chemiphar Co., Ltd. | P2x4 receptor antagonist |
| AU2015296135A1 (en) | 2014-08-01 | 2017-02-16 | The Johns Hopkins University | MrgprX2/MrgprB2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions |
| US20180338980A1 (en) | 2015-06-10 | 2018-11-29 | Bayer Pharma Aktiengesellschaft | Aromatic sulfonamide derivatives |
| PL3458443T3 (pl) | 2016-05-03 | 2021-03-08 | Bayer Pharma Aktiengesellschaft | Aromatyczne pochodne sulfonamidowe |
| CA3186937A1 (en) | 2020-08-03 | 2022-02-10 | Isao Matsuoka | Pharmaceutical composition for preventing, suppressing, or treating symptoms associated with allergic reaction |
-
2023
- 2023-03-30 JP JP2024512770A patent/JPWO2023190826A1/ja active Pending
- 2023-03-30 CA CA3246964A patent/CA3246964A1/en active Pending
- 2023-03-30 CN CN202380041406.1A patent/CN119233829A/zh active Pending
- 2023-03-30 WO PCT/JP2023/013084 patent/WO2023190826A1/ja not_active Ceased
- 2023-03-30 US US18/851,792 patent/US20260000678A1/en active Pending
- 2023-03-30 EP EP23780834.0A patent/EP4501357A1/en active Pending
- 2023-03-30 AU AU2023244778A patent/AU2023244778A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8871753B2 (en) | Macrocyclic compounds and their use as kinase inhibitors | |
| CN1267430C (zh) | 与多巴胺d3受体具有亲和力的三唑化合物 | |
| CN1165536C (zh) | 与六元杂环稠合的取代的吡唑衍生物 | |
| CN1898209A (zh) | 葡糖激酶调节剂吡啶羧酸衍生物 | |
| CN1934100A (zh) | 取代喹唑啉或吡啶并嘧啶衍生物 | |
| CN1703405A (zh) | 用作糖原合酶激酶3β抑制剂的氨基苯甲酰胺衍生物 | |
| CN1759111A (zh) | 咪唑－4－基－乙炔基－吡啶衍生物 | |
| CN1914199A (zh) | 具有蛋白激酶抑制活性的吡啶基或者嘧啶基噻唑化合物 | |
| CN1568185A (zh) | 影响葡糖激酶的化合物 | |
| CN1535266A (zh) | 用作mGluR2拮抗剂Ⅱ的二氢-苯并[b][1,4]二氮杂�-2-酮衍生物 | |
| CN1684957A (zh) | 作为组蛋白脱乙酰酶抑制剂的取代的噻吩基－异羟肟酸 | |
| CN1761672A (zh) | 噻吩并嘧啶二酮及其在调节自身免疫疾病中的用途 | |
| CN1070404A (zh) | 新的杂环衍生物 | |
| CN1628109A (zh) | 新颖的芳基－与杂芳基－哌嗪 | |
| CN1886377A (zh) | 用作葡糖激酶(glk)激活剂的苯甲酰基氨基吡啶基羧酸衍生物 | |
| CN1856480A (zh) | p38激酶抑制剂 | |
| CN1575284A (zh) | 作为激酶抑制剂的取代的三唑二胺衍生物 | |
| CN1312807A (zh) | 糖元合成酶激酶3的抑制剂 | |
| CN1376156A (zh) | 苯并二氮杂䓬衍生物、其制备和用途 | |
| CN101039915A (zh) | 用于治疗ⅱ型糖尿病和肥胖症的苯氧基苯甲酰胺化合物 | |
| CN1878759A (zh) | 哒嗪－3(2h)－酮衍生物及其作为pde4抑制剂的用途 | |
| CN1768051A (zh) | 取代的吡唑 | |
| CN1960984A (zh) | 作为mglu5受体拮抗剂的吡啶－4－基－乙炔基－咪唑和吡唑 | |
| CN1890242A (zh) | 吡唑并和咪唑并－嘧啶衍生物 | |
| JPWO2023190826A5 (https=) |